John A. Thompson

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald et al. · Journal of Clinical Oncology · 2001 · 2.4K citations

Medicine, Dermatology, Oncology +17

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · New England Journal of Medicine · 2016 · 1.2K citations · Full text

Medicine, Dermatology, Oncology +17

Adoptive T cell therapy using antigen-specific CD8 ⁺ T cell clones for the treatment of patients with metastatic melanoma: <i>In vivo</i> persistence, migration, and antitumor effect of transferred T cells

Cassian Yee, John A. Thompson, D. Byrd et al. · Proceedings of the National Academy of Sciences · 2002 · 1.2K citations

Medicine, Immunology, Oncology +17

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

Naomi Hunder, Herschel Wallen, Jianhong Cao et al. · New England Journal of Medicine · 2008 · 905 citations · Full text

Medicine, Immunology, Oncology +17